NO315546B1 - Inhibisjon av retro virusinfeksjon - Google Patents

Inhibisjon av retro virusinfeksjon Download PDF

Info

Publication number
NO315546B1
NO315546B1 NO19950897A NO950897A NO315546B1 NO 315546 B1 NO315546 B1 NO 315546B1 NO 19950897 A NO19950897 A NO 19950897A NO 950897 A NO950897 A NO 950897A NO 315546 B1 NO315546 B1 NO 315546B1
Authority
NO
Norway
Prior art keywords
slpi
hiv
cells
infection
mutein
Prior art date
Application number
NO19950897A
Other languages
English (en)
Norwegian (no)
Other versions
NO950897D0 (no
NO950897L (no
Inventor
Stephen P Eisenberg
Sharon M Wahl
Robert C Thompson
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of NO950897D0 publication Critical patent/NO950897D0/no
Publication of NO950897L publication Critical patent/NO950897L/no
Publication of NO315546B1 publication Critical patent/NO315546B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19950897A 1992-09-09 1995-03-08 Inhibisjon av retro virusinfeksjon NO315546B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94336992A 1992-09-09 1992-09-09
PCT/US1993/008486 WO1994006454A2 (en) 1992-09-09 1993-09-09 Inhibitiion of retrovirus infection

Publications (3)

Publication Number Publication Date
NO950897D0 NO950897D0 (no) 1995-03-08
NO950897L NO950897L (no) 1995-03-08
NO315546B1 true NO315546B1 (no) 2003-09-22

Family

ID=25479533

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19950897A NO315546B1 (no) 1992-09-09 1995-03-08 Inhibisjon av retro virusinfeksjon

Country Status (23)

Country Link
EP (1) EP0666755B1 (ru)
JP (2) JP3517238B2 (ru)
KR (1) KR100273620B1 (ru)
AT (1) ATE238062T1 (ru)
AU (1) AU681350B2 (ru)
CA (1) CA2141951C (ru)
CZ (1) CZ286953B6 (ru)
DE (1) DE69332904T2 (ru)
DK (1) DK0666755T3 (ru)
ES (1) ES2197153T3 (ru)
FI (1) FI951078L (ru)
HU (1) HU218892B (ru)
NO (1) NO315546B1 (ru)
NZ (1) NZ256246A (ru)
OA (1) OA10133A (ru)
PL (1) PL307864A1 (ru)
PT (1) PT666755E (ru)
RO (1) RO116164B1 (ru)
RU (1) RU2126266C1 (ru)
SG (1) SG48115A1 (ru)
SK (1) SK281127B6 (ru)
UA (1) UA41338C2 (ru)
WO (1) WO1994006454A2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900401A (en) * 1994-03-23 1999-05-04 Tokyo Tanabe Company Limited Remedy for respiratory-tract viral disease
WO1997003694A1 (en) * 1995-07-24 1997-02-06 Tokyo Tanabe Company Limited Remedy for viral diseases
AU7508196A (en) 1995-11-13 1997-06-05 Gerard Voerman Anti-viral isolates obtainable from leeches
US7276333B1 (en) 1999-05-13 2007-10-02 Japan Science And Technology Agency Viral infection inhibitor targeting integrase N-terminal domain
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
WO2005046732A2 (en) 2003-11-04 2005-05-26 THE UNITED SATES OF AMERICA as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH Methods and compositions for the inhibition of hiv-1 replication

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
CA2007083A1 (en) * 1989-01-09 1990-07-09 Nobuhiko Katunuma Pharmaceutical use of trypstatin
ATE148992T1 (de) * 1989-08-16 1997-03-15 Chiron Corp Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen
AU644621B2 (en) * 1989-12-18 1993-12-16 Transgene S.A. Pharmaceutical composition for treating or preventing retroviral infections
GR1001044B (el) * 1991-06-03 1993-04-28 Logothetou Rella Eleni Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

Also Published As

Publication number Publication date
HU9500682D0 (en) 1995-04-28
AU4853093A (en) 1994-04-12
CZ286953B6 (en) 2000-08-16
CA2141951C (en) 2007-04-24
DE69332904T2 (de) 2003-11-06
AU681350B2 (en) 1997-08-28
EP0666755B1 (en) 2003-04-23
NO950897D0 (no) 1995-03-08
FI951078A0 (fi) 1995-03-08
ATE238062T1 (de) 2003-05-15
RU95109909A (ru) 1997-03-27
HUT75126A (en) 1997-04-28
SG48115A1 (en) 1998-04-17
SK29795A3 (en) 1997-02-05
KR100273620B1 (ko) 2000-12-15
UA41338C2 (ru) 2001-09-17
PT666755E (pt) 2003-09-30
JPH08505042A (ja) 1996-06-04
KR950703357A (ko) 1995-09-20
EP0666755A1 (en) 1995-08-16
NO950897L (no) 1995-03-08
RU2126266C1 (ru) 1999-02-20
WO1994006454A2 (en) 1994-03-31
PL307864A1 (en) 1995-06-26
CZ55995A3 (en) 1996-01-17
NZ256246A (en) 1997-08-22
JP2004002455A (ja) 2004-01-08
FI951078A7 (fi) 1995-03-08
DK0666755T3 (da) 2003-08-04
WO1994006454A3 (en) 1994-08-18
ES2197153T3 (es) 2004-01-01
DE69332904D1 (de) 2003-05-28
SK281127B6 (sk) 2000-12-11
CA2141951A1 (en) 1994-03-31
RO116164B1 (ro) 2000-11-30
HU218892B (hu) 2000-12-28
OA10133A (en) 1996-12-18
FI951078L (fi) 1995-03-08
JP3517238B2 (ja) 2004-04-12

Similar Documents

Publication Publication Date Title
AU723537B2 (en) The treatment of HIV and other viral infections using combinatorial therapy
WO1991018010A1 (en) Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
US6017880A (en) Inhibition of retrovirus infection
RU2290197C2 (ru) Фармацевтическое средство для лечения вич-инфекции, содержащая его композиция и способы его применения
NO315546B1 (no) Inhibisjon av retro virusinfeksjon
US6869925B1 (en) Inhibition of retrovirus infection
JPWO2008050830A1 (ja) 抗ｈｉｖ剤
WO1990008198A1 (en) Compositions and methods for treating or preventing aids, arc and hiv infection
WO1997025350A1 (en) Use of chemokines for the treatment and prevention of hiv infection
Pomerantz et al. Therapy of human immunodeficiency virus infections
EP2667886A1 (en) Antiviral peptides
Agentsa Implications for the Design of Small-Peptide
HK1067531B (en) A pharmaceutical composition for treating hiv infection
CN101397331A (zh) 酶抑制剂及其制法和用途
WO1998026660A1 (en) Cd4-mimetic ligands
WO2012101616A1 (en) Antiviral peptides
MXPA97009682A (en) The treatment of hiv infections and other viral infections using a combined therapy
EP0696202A1 (en) Pharmaceutical composition containing thymoctonan and azt